CSL Limited (CSL) - Financial and Strategic SWOT Analysis Review

Date: October 12, 2016
Pages: 57
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CA09B25782BEN
Leaflet:

Download PDF Leaflet

CSL Limited (CSL) - Financial and Strategic SWOT Analysis Review
CSL Limited (CSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

CSL Limited (CSL) carries out research and development, manufacturing, marketing and distribution of biopharmaceutical and related products. Its product portfolio include plasma-derived products for treating bleeding disorders such as haemophilia and von Willebrand disease, hereditary angioedema, primary and secondary immune deficiencies, inherited respiratory disease and neurological disorders; influenza vaccine; and protein-based medicines for treating serious human illnesses. The company also provides products to prevent haemolytic disease in newborns and infection in solid organ transplant recipients and to treat specific infections and help victims of trauma, shock and burns.

CSL Limited Key Recent Developments

Aug 17,2016 CSL Announces Full Year Result 2016
Aug 17,2016 CSL Announces Changes to the Board
Jul 04,2016 CSL to Support new Biopharmaceutical Training Centre at UQ
Jun 06,2016 Seqirus donates vaccines to Fiji to alleviate increase in influenza

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

CSL Limited - Key Facts
CSL Limited - Key Employees
CSL Limited - Key Employee Biographies
CSL Limited - Major Products and Services
CSL Limited - Pharmaceutical Pipeline Products Data
CSL Limited, Pipeline Products by Therapy Area
CSL Limited, Pipeline Products by Development Phase
CSL Limited - History
CSL Limited - Company Statement
CSL Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

CSL Limited - Business Description
CSL Limited - Corporate Strategy
CSL Limited - SWOT Analysis
SWOT Analysis - Overview
CSL Limited - Strengths
CSL Limited - Weaknesses
CSL Limited - Opportunities
CSL Limited - Threats
CSL Limited - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

CSL Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
CSL Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
CSL Limited, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 17, 2016: CSL Announces Full Year Result 2016
Aug 17, 2016: CSL Announces Changes to the Board
Jul 04, 2016: CSL to Support new Biopharmaceutical Training Centre at UQ
Jun 06, 2016: Seqirus donates vaccines to Fiji to alleviate increase in influenza
Apr 14, 2016: CSL Announces $25 million Centenary Fellowship Program
Mar 07, 2016: Expanded Bio21 to house global research hub
Feb 16, 2016: CSL Appoints New Director
Feb 16, 2016: CSL: Half Year Result 2016
Nov 09, 2015: CSL brands world’s no. 2 influenza vaccine provider as Seqirus
Oct 09, 2015: CSL Names David Lamont as Chief Financial Officer

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

CSL Limited, Key Facts
CSL Limited, Key Employees
CSL Limited, Key Employee Biographies
CSL Limited, Major Products and Services
CSL Limited, Number of Pipeline Products by Therapy Area
CSL Limited, Number of Pipeline Products by Development Stage
CSL Limited, Pipeline Products By Therapy Area and Development Phase
CSL Limited, History
CSL Limited, Other Locations
CSL Limited, Subsidiaries
CSL Limited, Key Competitors
CSL Limited, Ratios based on current share price
CSL Limited, Annual Ratios
CSL Limited, Interim Ratios
CSL Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
CSL Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
CSL Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

CSL Limited, Pipeline Products by Therapy Area
CSL Limited, Pipeline Products by Development Phase
CSL Limited, Performance Chart (2012 - 2016)
CSL Limited, Ratio Charts
CSL Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
CSL Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

CSL Limited (CSL) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: